Myriad Genetics | MYGN - Ebitda

سعر السهم
4.74
التغيير اليومي
0.06 1.28%
شهريا
5.33%
سنويا
-33.52%
Q2 التوقعات
4.68




Ebitda تغيير تاريخ
Agilent USD 540M 74M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Bio-Rad Laboratories USD 983.8M 1.36B 2025-12
Bruker USD 211.6M 207.4M 2025-12
Danaher USD 1.92B 204M 2026-03
Illumina USD 469M 137M 2025-12
J&J USD 7.19B 2.32B 2025-12
Mettler Toledo International USD 322.64M 26.75M 2025-09
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Quest Diagnostics USD 557M 20M 2026-03
Quidel USD 153.3M 23.8M 2025-12
Repligen USD 39.54M 3.61M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Standard Biotools USD -15.81M 734K 2025-12
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Veracyte USD 42.31M 2.58M 2025-12
Waters USD 380.97M 85.83M 2025-12